Education and Outreach Blog

« Back

Engility Awarded $112M Contract for Scientific Computing by the FDA

Engility Holdings, Inc. (NYSE: EGL), today announced it was awarded a $112 million single-award indefinite delivery/indefinite quantity (IDIQ) contract by the Food and Drug Administration (FDA) Scientific Computing Board and Office of Information Management and Technology (OIMT). Engility will deliver services unique to computational science and bioinformatics, a discipline that promotes gene-based drug discovery and development. “With this award, Engility expands on our long-standing partnership with the FDA to further develop their high performance computing and complex data analysis capabilities,” said Engility CEO Lynn Dugle. “We look forward to supporting the FDA’s mission to make groundbreaking treatments, such as genetics-based medicine, available to all Americans.” As part of the OIMT contract, the Engility team will provide security, operations and maintenance, and technical support for scientific computing environments and systems. Engility will help the FDA build fast, reliable and adaptable high performance computing architectures that accommodate analyses of complex data sets. These capabilities are critical to answer FDA’s front-line needs, such as rapid genomics analyses that address emerging threats to America’s food supply and adverse event studies of new personalized medicine therapies. The services Engility provides under the contract will enable better insights through faster, better-informed regulatory decisions and secure collaboration among FDA scientists and the worldwide scientific community. Engility will work with the Office of Acquisition & Grants Services, FDA Centers and OIMT leadership to apply scientific computing to regulatory-science innovations. Read more at

Trackback URL:

No comments yet. Be the first.